Oritavancin (LY 333328) 是一种具有口服活性的糖肽抗生素(antibiotic),对革兰氏阳性菌具有活性。Oritavancin 对多重耐药性S. pneumoniae表现出抗菌(antibacterial)作用。Oritavancin 抑制细胞壁合成,破坏膜电位。
生物活性 | Oritavancin (LY 333328) is an orally activeglycopeptideantibioticwith activity against gram-positive organisms. Oritavancin showsantibacterialeffect against multidrug-resistantS. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. |
IC50& Target | |
Clinical Trial | |
分子量 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |